ORTHO Optix Reader is supported by Ortho Care™, Ortho's award-winning, holistic service and support solution, and is now available in countries that accept CE Mark.
With high sensitivity and specificity,ii Ortho's SARS-CoV-2 antigen test offers exceptional utility for mass-scale testing where appropriate.
The company are trusted partners of hospitals, hospital networks, blood banks, and labs around the world, serving the clinical laboratory and transfusion medicine communities with customized solutions that enhance clinical outcomes, improve lab performance, overcome staffing challenges and better manage costs.
This test is one of only a handful of antibody tests to be granted Emergency Use Authorization.
VITROS XT Solutions, which include the new VITROS XT 3400 Chemistry System and the VITROS® XT 7600 Integrated System with new XT MicroSlides, help ensure the right result the first time, expediting critical health information to clinicians who can make decisions faster and ultimately improve patient outcomes.
During pre-transfusion testing, lab professionals routinely encounter complex patient samples that require extended antigen typing.
By combining Ortho's proprietary dry slide technology with sophisticated digital imaging capabilities and the potential to perform two separate lab tests simultaneously, Ortho is introducing digital chemistry to clinical lab management.